Editorial: dietary interventions to understand and treat primary sclerosing cholangitis—is gluten‐free diet a starting point?

A prospective pilot study of a gluten‐free diet for primary sclerosing cholangitis and associated colitis

(2022) Timur Liwinski et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Transcriptomics Identify Thrombospondin‐2 as a Biomarker for NASH and Advanced Liver Fibrosis

(2021) Kazuhiro Kozumi et al.   HEPATOLOGY

Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis

(2017) Mette Vesterhus et al.   JOURNAL OF HEPATOLOGY

A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease

(2015) J. E. Eaton et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Tissue-based map of the human proteome

(2015) M. Uhlen et al.   SCIENCE

Reduced Coffee Consumption Among Individuals With Primary Sclerosing Cholangitis but Not Primary Biliary Cirrhosis

(2014) Craig Lammert et al.   Clinical Gastroenterology and Hepatology

Effects of Coffee Consumption, Smoking, and Hormones on Risk for Primary Sclerosing Cholangitis

(2013) Ina Marie Andersen et al.   Clinical Gastroenterology and Hepatology

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

(2013) Jimmy Z Liu et al.   NATURE GENETICS

Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4

(2012) Yvonne Junker et al.   JOURNAL OF EXPERIMENTAL MEDICINE